Bioforce Nanosciences Holdings, Inc.

BioForce Nanosciences Holdings, Inc. is a U.S.-based microcap company that has shifted away from its original nanotechnology roots into nutritional supplements. Its current business centers on the BioForce Eclipse powder multivitamin and mineral supplement, which it private-labels through a Virginia manufacturer and distributes through retail and online channels. The company says it is trying to build brand awareness through social media, telemarketing, direct marketing, and B2B sales. It remains in an early commercial stage and has disclosed that it does not yet generate enough revenue to cover operating expenses.

0.00

0.00

— Bioforce Nanosciences Holdings, Inc.
%
Nutritional supplements100% Powdered multivitamin and mineral supplements sold under the BioForce Eclipse brand.
Private-label product sourcing0% Supplement products manufactured by third parties and sold under private-label arrangements.

BioForce targets retail and wholesale buyers that can place its supplement products into consumer channels, including...

  • Retail channel partnersprimary

    Retailers, grocery stores, pharmacies, and mass merchandisers that buy supplement products for resale because they want branded wellness items with consumer demand.

  • Online marketplacesprimary

    E-commerce channels such as Amazon that buy or list the product to reach consumers directly and broaden geographic reach.

  • B2B distributorsprimary

    Distributors and vendor partners that help place the product into multiple outlets and support the company's direct marketing strategy.

  • Institutional and facility buyerssecondary

    Hospitals, clinics, universities, nursing homes, prisons, and similar facilities that may purchase vitamin and mineral supplements for on-site use or resale.

  • End consumersprimary

    Health-conscious and active individuals who consume the Eclipse powder and related supplements for nutrition support.

The company is headquartered in the United States and describes the U.S. as its core and intended expansion market...

  • •United States is the primary and intended expansion market
  • •Management plans nationwide U.S. rollout rather than international expansion
  • •Private-label manufacturing is currently located in Virginia
  • •Sales and marketing are focused on U.S. retail and online channels
  • •No country-level revenue split was disclosed in the excerpts

BioForce's near-term strategy is to build a viable supplement business around BioForce Eclipse and related nutritional...

01
Brand and demand generationshort-term

The company needs consumer awareness to create pull-through demand and convince retailers to carry the product.

02
Channel expansionshort-term

Broader retail and online distribution is necessary to scale sales beyond a limited set of outlets.

03
Supply chain and sourcing optimizationmedium-term

The company wants to reduce product cost and improve economics while maintaining quality.

04
Capital preservation and financingshort-term

The company has disclosed insufficient revenues and ongoing cash needs, making financing essential to continue operations.

The most immediate risk is going concern and liquidity risk, because management states that the company does not have...

critical

Going concern and liquidity shortfall

Management states that the company does not have sufficient revenues to cover operating expenses and needs additional capital to continue operations.

Scope
Entire business
Materiality
high
high

Dependence on external financing and related parties

Recent cash inflows came from related parties and capital contributions, indicating the business depends on non-operating funding.

Scope
Cash flow and continuity
Materiality
high
high

Commercial adoption risk

The company is still trying to establish brand awareness and reported no orders in one disclosed quarter, showing uncertain demand.

Scope
Revenue generation
Materiality
high
medium

Third-party manufacturing and private-label dependence

The product is manufactured by an outside supplier and the distributor owns the formula rights, limiting control over supply and economics.

Scope
Product availability and margins
Materiality
medium
medium

Supplement regulation and product quality

Dietary supplements are subject to FDA rules and quality expectations, which can affect market access and liability.

Scope
Compliance and reputation
Materiality
medium
Revenue recognition under ASC 606
Can shift reported sales between periods
Impairment of long-lived assets
Can create material non-cash charges
Accrued compensation and payables
Affects liabilities, expenses, and cash flow
Going concern disclosures
Important for valuation and financial statement interpretation

Bio Essence Corp

BIOE · Pharmaceutical Preparations

CapForce Inc.

CFOR · Services-Medical Laboratories

IMPACT BIOMEDICAL INC.

IBO · Pharmaceutical Preparations

Nanoform Finland Oyj

NANOFH.HE · Biotechnology

NANOVIRICIDES, INC.

NNVC · Pharmaceutical Preparations

PULSE BIOSCIENCES, INC.

PLSE · Surgical & Medical Instruments & Apparatus

: 11/08/2026